BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30530830)

  • 1. Fully Automated
    Poot AJ; Adamzek KWA; Windhorst AD; Vosjan MJWD; Kropf S; Wester HJ; van Dongen GAMS; Vugts DJ
    J Nucl Med; 2019 May; 60(5):691-695. PubMed ID: 30530830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Induced Radiosynthesis of
    Klingler S; Fay R; Holland JP
    J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
    Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of
    Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated light-induced synthesis of
    Klingler S; Holland JP
    Sci Rep; 2022 Jan; 12(1):668. PubMed ID: 35027637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and Semi-Automated Processing of
    Gaja V; Cawthray J; Geyer CR; Fonge H
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32516930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generic
    Li N; Yu Z; Pham TT; Blower PJ; Yan R
    Int J Nanomedicine; 2017; 12():3281-3294. PubMed ID: 28458546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.
    Bhattacharyya S; Kurdziel K; Wei L; Riffle L; Kaur G; Hill GC; Jacobs PM; Tatum JL; Doroshow JH; Kalen JD
    Nucl Med Biol; 2013 May; 40(4):451-7. PubMed ID: 23454247
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
    Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Development of CD38-Targeted [
    Ghai A; Maji D; Cho N; Chanswangphuwana C; Rettig M; Shen D; DiPersio J; Akers W; Dehdashti F; Achilefu S; Vij R; Shokeen M
    J Nucl Med; 2018 Feb; 59(2):216-222. PubMed ID: 29025987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.
    Jagoda EM; Vasalatiy O; Basuli F; Opina ACL; Williams MR; Wong K; Lane KC; Adler S; Ton AT; Szajek LP; Xu B; Butcher D; Edmondson EF; Swenson RE; Greiner J; Gulley J; Eary J; Choyke PL
    Mol Imaging; 2019; 18():1536012119829986. PubMed ID: 31044647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated radiosynthesis of [
    Wichmann CW; Poniger S; Guo N; Roselt P; Rudd SE; Donnelly PS; Blyth B; Van Zuylekom J; Rigopoulos A; Burvenich IJG; Morandeau L; Mohamed S; Nowak AK; Hegi-Johnson F; MacManus M; Scott AM
    Nucl Med Biol; 2023; 120-121():108351. PubMed ID: 37224789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
    J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Routine
    Wuensche TE; Nauta S; van Dongen GAMS; Vugts DJ
    J Labelled Comp Radiopharm; 2024 May; ():. PubMed ID: 38744538
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pandya DN; Bhatt NB; Almaguel F; Rideout-Danner S; Gage HD; Solingapuram Sai KK; Wadas TJ
    J Nucl Med; 2019 May; 60(5):696-701. PubMed ID: 30442753
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice.
    Waaijer SJH; Suurs FV; Hau CS; Vrijland K; de Visser KE; de Groot DJA; de Vries EGE; Lub-de Hooge MN; Schröder CP
    Front Oncol; 2021; 11():786191. PubMed ID: 34976826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
    Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.